Organigram Global Statistics
Share Statistics
Organigram Global has 133.84M
shares outstanding. The number of shares has increased by 22.1%
in one year.
| Shares Outstanding | 133.84M |
| Shares Change (YoY) | 22.1% |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | 6.81% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,703 |
| FTD / Avg. Volume | 0.75% |
Short Selling Information
The latest short interest is 6.65M, so 0% of the outstanding
shares have been sold short.
| Short Interest | 6.65M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 15.09 |
Valuation Ratios
The PE ratio is -5.13 and the forward
PE ratio is null.
Organigram Global's PEG ratio is
0.06.
| PE Ratio | -5.13 |
| Forward PE | n/a |
| PS Ratio | 1.46 |
| Forward PS | 0.5 |
| PB Ratio | 0.76 |
| P/FCF Ratio | -159.14 |
| PEG Ratio | 0.06 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Organigram Global.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.92,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.92 |
| Quick Ratio | 3.37 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.19 |
| Debt / FCF | -3.04 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $146,240.62 |
| Profits Per Employee | $-41,573.65 |
| Employee Count | 1,093 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -25.27% in the
last 52 weeks. The beta is 1.82, so Organigram Global's
price volatility has been higher than the market average.
| Beta | 1.82 |
| 52-Week Price Change | -25.27% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 67.25 |
| Average Volume (20 Days) | 628,252 |
Income Statement
In the last 12 months, Organigram Global had revenue of 159.84M
and earned -45.44M
in profits. Earnings per share was -0.48.
| Revenue | 159.84M |
| Gross Profit | 47.52M |
| Operating Income | -35.67M |
| Net Income | -45.44M |
| EBITDA | -23.59M |
| EBIT | -35.67M |
| Earnings Per Share (EPS) | -0.48 |
Full Income StatementBalance Sheet
The company has 106.75M in cash and 4.46M in
debt, giving a net cash position of 102.29M.
| Cash & Cash Equivalents | 106.75M |
| Total Debt | 4.46M |
| Net Cash | 102.29M |
| Retained Earnings | -583.97M |
| Total Assets | 537.9M |
| Working Capital | 182.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 3.87M
and capital expenditures -5.34M, giving a free cash flow of -1.47M.
| Operating Cash Flow | 3.87M |
| Capital Expenditures | -5.34M |
| Free Cash Flow | -1.47M |
| FCF Per Share | -0.02 |
Full Cash Flow StatementMargins
Gross margin is 29.73%, with operating and profit margins of -22.32% and -28.43%.
| Gross Margin | 29.73% |
| Operating Margin | -22.32% |
| Pretax Margin | -28.43% |
| Profit Margin | -28.43% |
| EBITDA Margin | -14.76% |
| EBIT Margin | -22.32% |
| FCF Margin | -0.92% |
